1. Home
  2. Analysis
  3. Memantine-hydrochloride
  4. Baby-aspirin

Memantine hydrochloride and Baby aspirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 7 people who take Memantine hydrochloride and Baby aspirin. Common interactions include oesophageal disorder among females, and arrhythmia among males.

The phase IV clinical study analyzes what interactions people who take Memantine hydrochloride and Baby aspirin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

7 people who take Memantine hydrochloride and Baby aspirin together, and have interactions are studied.

What is Memantine hydrochloride?

Memantine hydrochloride has active ingredients of memantine hydrochloride. Currently, eHealthMe is studying from 2,866 Memantine hydrochloride users.

What is Baby aspirin?

Baby aspirin has active ingredients of aspirin. It is used in blood clots. Currently, eHealthMe is studying from 24,564 Baby aspirin users.

Number of Memantine hydrochloride and Baby aspirin reports submitted per year:

Memantine hydrochloride and Baby aspirin drug interactions.

Common Memantine Hydrochloride and Baby Aspirin drug interactions by gender *:

female:

  1. Oesophageal disorder
  2. Weight decreased

male:

  1. Arrhythmia
  2. Chronic obstructive pulmonary disease
  3. Haematochezia
  4. Myocardial infarction
  5. Pneumonia
  6. Rheumatoid arthritis
  7. Thrombosis
  8. Dehydration
  9. Dementia
  10. Diverticulitis

Common Memantine Hydrochloride and Baby Aspirin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Glaucoma
  2. Myocardial infarction
  3. Rheumatoid arthritis
  4. Arrhythmia
  5. Chronic obstructive pulmonary disease
  6. Dementia

50-59:

n/a

60+:

  1. Diverticulitis
  2. Gastrointestinal haemorrhage
  3. Haematochezia
  4. Oesophageal disorder
  5. Pneumonia
  6. Thrombosis
  7. Weight decreased

* Approximation only. Some reports may have incomplete information.

Do you take Memantine hydrochloride and Baby aspirin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Memantine hydrochloride drug interactions:

Browse interactions between Memantine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Baby aspirin drug interactions:

Browse interactions between Baby aspirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on memantine hydrochloride and aspirin (the active ingredients of Memantine hydrochloride and Baby aspirin, respectively), and Memantine hydrochloride and Baby aspirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Memantine hydrochloride and Baby aspirin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.